News | November 12, 2006

ACC, AHA Launch New Door-to-Balloon Campaign

ACC together with AHA and other key healthcare organizations, has launched "Door to Balloon (D2B): An Alliance for Quality." A Guidelines Applied in Practice (GAP) Program, the D2B campaign is aimed at improving the timeliness of lifesaving therapy for patients with heart attacks at the nation's hospitals that perform emergency angioplasty.

Door-to-balloon time refers to the interval between arrival at the
hospital and the opening of a blocked artery with an angioplasty balloon. Patients who receive prompt treatment are more likely to survive a common type of heart attack called ST-elevation myocardial infarction (STEMI).

Previously published ACC/AHA guidelines recommend a 90-minute D2B standard, but it does pose organizational challenge, and many patients are not treated within that timeframe.

"The D2B campaign provides a great way for the nation's hospitals to come together and make a promise to their patients that they will deliver rapid care and eliminate needless delays," says Harlan M. Krumholz, M.D., S.M., F.A.C.C., chair of the D2B Working Group. "In essence, by working together, we can make what is currently extraordinary performance, achieved by only a few hospitals, something that is routine and ordinary in clinical practice, ensuring that patients across the country with STEMI receive the proper treatment that they need."

"The introduction of this new campaign is a giant step toward
increasing the quality of patient care for heart attack patients," said Raymond Gibbons, M.D., F.A.C.C., president of the American Heart Association. "It will help these hospitals to deliver the best possible care to every patient."

Specific strategies for accomplishing the D2B recommendation include: (1.) The emergency medicine physicians activate the catheterization laboratory (cath lab); (2.) A single call activates the cath lab; (3.) The cath lab team arrives and is ready within 20-30 minutes; (4.) Real-time data feedback in the ED and the cath lab;.

Over the coming months, participating hospitals will receive an
implementation manual and tool kit, as well as information on how to best construct the team needed to implement the changes; what the roles and responsibilities of each member should be; and how to identify the point person for the project within each primary PCI hospital. An update on the campaign will be given at ACC.07, in New Orleans, March 24-27.

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Overlay Init